DANIELLE BEATTY: Open Payments
NPI 1659811453 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 97 payments from 35 companies in 2025. Trend: 2023 $1,849 · 2024 $1,540 · 2025 $2,235
Food & beverage: $2,235
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $174 |
| PFIZER INC. | 7 | $171 |
| Novartis Pharmaceuticals Corporation | 7 | $166 |
| ABBVIE INC. | 5 | $159 |
| Regeneron Healthcare Solutions, Inc. | 5 | $156 |
| Gilead Sciences, Inc. | 6 | $139 |
| Eisai Inc. | 7 | $123 |
| Daiichi Sankyo Inc. | 4 | $100 |
| Astellas Pharma US Inc | 4 | $82 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $72 |
Products named: LIBTAYO, KISQALI, Trodelvy, IMBRUVICA, Lenvima, IBRANCE, JAKAFI, Enhertu.
Industry payments across FL — which companies pay providers there.
